Arrowstreet Capital, Limited Partnership Sanofi Transaction History

Arrowstreet Capital, Limited Partnership

$122 Billion
Q4 2024

A detailed history of Arrowstreet Capital, Limited Partnership transactions in Sanofi stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 279,893 shares of SNY stock, worth $15.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

279,893

Previous 341,864 18.13%

Holding current value

$15.3 Million

Previous $19.7 Million 31.5%

% of portfolio

0.01%

Previous 0.02%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$45.89 - $57.31 $2.84 Million - $3.55 Million	-61,971 Reduced 18.13%	279,893 $13.5 Million
Q3 2024 Nov 14, 2024	BUY	$48.54 - $58.53 $1.24 Million - $1.49 Million	25,452 Added 8.04%	341,864 $19.7 Million
Q2 2024 Aug 14, 2024	BUY	$45.39 - $50.36 $6.68 Million - $7.41 Million	147,221 Added 87.01%	316,412 $15.4 Million
Q1 2024 May 15, 2024	BUY	$45.75 - $52.48 $2.54 Million - $2.91 Million	55,518 Added 48.84%	169,191 $8.22 Million
Q4 2023 Feb 14, 2024	SELL	$43.13 - $54.79 $20.1 Million - $25.5 Million	-465,675 Reduced 80.38%	113,673 $5.65 Million
Q3 2023 Nov 14, 2023	SELL	$50.95 - $55.2 $12.3 Million - $13.3 Million	-241,122 Reduced 29.39%	579,348 $31.1 Million
Q2 2023 Aug 14, 2023	SELL	$50.45 - $57.18 $76.5 Million - $86.7 Million	-1,516,382 Reduced 64.89%	820,470 $44.2 Million
Q1 2023 May 15, 2023	SELL	$45.86 - $54.45 $50 Million - $59.3 Million	-1,089,377 Reduced 31.8%	2,336,852 $127 Million
Q4 2022 Feb 14, 2023	SELL	$38.86 - $48.55 $22.3 Million - $27.8 Million	-573,617 Reduced 14.34%	3,426,229 $166 Million
Q3 2022 Nov 14, 2022	BUY	$37.22 - $100.5 $9.25 Million - $25 Million	248,615 Added 6.63%	3,999,846 $152 Million
Q2 2022 Aug 15, 2022	BUY	$48.99 - $57.46 $19.1 Million - $22.4 Million	389,119 Added 11.57%	3,751,231 $188 Million
Q1 2022 May 13, 2022	BUY	$48.48 - $53.65 $120 Million - $132 Million	2,468,271 Added 276.14%	3,362,112 $173 Million
Q4 2021 Feb 14, 2022	BUY	$47.07 - $52.35 $3.44 Million - $3.83 Million	73,090 Added 8.91%	893,841 $44.8 Million
Q3 2021 Nov 12, 2021	BUY	$47.89 - $53.12 $15.5 Million - $17.2 Million	323,503 Added 65.06%	820,751 $39.6 Million
Q2 2021 Aug 13, 2021	SELL	$49.36 - $54.25 $45.1 Million - $49.6 Million	-914,417 Reduced 64.78%	497,248 $26.2 Million
Q1 2021 May 14, 2021	BUY	$45.46 - $50.51 $16.1 Million - $17.9 Million	353,665 Added 33.43%	1,411,665 $69.8 Million
Q4 2020 Feb 12, 2021	SELL	$45.3 - $51.62 $294,450 - $335,530	-6,500 Reduced 0.61%	1,058,000 $51.4 Million
Q3 2020 Nov 12, 2020	SELL	$49.47 - $53.77 $1.94 Million - $2.11 Million	-39,314 Reduced 3.56%	1,064,500 $53.4 Million
Q2 2020 Aug 12, 2020	SELL	$42.91 - $52.5 $3.85 Million - $4.72 Million	-89,838 Reduced 7.53%	1,103,814 $56.4 Million
Q1 2020 May 15, 2020	BUY	$38.02 - $51.66 $45.4 Million - $61.7 Million	1,193,652 New	1,193,652 $52.2 Million
Q3 2019 Nov 14, 2019	SELL	$40.34 - $46.64 $42.1 Million - $48.7 Million	-1,043,595 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$40.43 - $44.3 $1.77 Million - $1.94 Million	43,792 Added 4.38%	1,043,595 $45.2 Million
Q1 2019 May 15, 2019	BUY	$40.83 - $45.43 $14.3 Million - $15.9 Million	350,218 Added 53.91%	999,803 $44.3 Million
Q4 2018 Feb 14, 2019	BUY	$41.48 - $45.59 $26.7 Million - $29.3 Million	643,585 Added 10726.42%	649,585 $28.2 Million
Q3 2018 Nov 14, 2018	SELL	$40.0 - $44.84 $35.6 Million - $39.9 Million	-889,452 Reduced 99.33%	6,000 $268,000
Q2 2018 Aug 14, 2018	BUY	$37.63 - $41.22 $13.8 Million - $15.2 Million	367,863 Added 69.73%	895,452 $35.8 Million
Q1 2018 May 14, 2018	BUY	$38.98 - $45.76 $20.6 Million - $24.1 Million	527,589 New	527,589 $21.1 Million

Others Institutions Holding SNY

# of Institutions

800

Shares Held

277M

Call Options Held

2.07M

Put Options Held

1.85M

View Full List

About Sanofi

Ticker SNY
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,508,100,096
Market Cap $137B
Description
Sanofi, together with its subsidiaries, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through three segments: Pharmaceuticals, Vaccines, and Consumer Healthcare. The company provides specialty care products, including human monoclonal antib...

More about SNY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.

Account

Arrowstreet Capital, Limited Partnership Sanofi Transaction History